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Abstract: Retinal migraine was first formally described in 1882. Various terms such as “ocular
migraine” and “ophthalmic migraine” have since been used interchangeably in the literature. The
lack of a consistent consensus-based definition has led to controversy and potential confusion for
clinicians and patients. Retinal migraine as defined by the International Classification of Headache
Disorders (ICHD) has been found to be rare. The latest ICHD defined retinal migraine as ‘repeated
attacks of monocular visual disturbance, including scintillation, scotoma or blindness, associated with
migraine headache’, which are fully reversible. Retinal migraine should be considered a diagnosis of
exclusion, which requires other causes of transient monocular visual loss to be excluded. The aim of
this narrative review is to summarize the literature on retinal migraine, including: epidemiology and
risk factors; proposed aetiology; clinical presentation; and management strategies. It is potentially a
misnomer as its proposed aetiology is different from our current understanding of the mechanism
of migraine
Keywords: retinal migraine; ocular migraine; ophthalmic migraine; migraine aura
1. Introduction and Historical Evolution
There has been extensive documentation of migraine as a disorder, dating back to over
4000 years ago from ancient Mesopotamia [1]. One of the earliest descriptions of visual
symptoms associated with migraine was a case report by Hippocrates (c. 460—c. 370 BC) in
ancient Greece [1]:
‘he seemed to see something shining before him like a light, usually in part of the
right eye; at the end of a moment, a violent pain supervened in the right temple,
then in all the head and neck. vomiting, when it became possible, was able to
divert the pain and render it more moderate.’
In 1882, Galezowski first used the term ophthalmic megrim to describe a case series
of four patients with permanent monocular visual loss and migraine headaches. He
hypothesized that ophthalmic megrim is a condition that may ‘occasionally lead to organic
changes in the retina or retinal vessels’, with findings such as retinal thrombosis and optic disc
atrophy [2].
The term retinal migraine was first introduced by Caroll in 1970 when he suggested
that although controversial, it could ‘possibly be applied to uncommon cases’ of migraine [3].
He presented a case series of 15 patients with monocular visual loss without associated
features of headache, mostly transient with a duration of less than 10 min and rarely lasting
more than an hour. A few cases had permanent visual loss resulting in optic atrophy,
which he hypothesized was secondary to raised intraocular pressure from paroxysmal
vasoconstriction of the central retinal artery or the ophthalmic artery.
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Without an internationally agreed definition, authors have used various terms inter-
changeably to describe monocular visual loss, which is either: associated with headache,
not associated with headache, transient, or permanent. These terms include ‘ophthalmic
migraine’, ‘ocular migraine’, and anterior pathway migraine [4–7].
Retinal migraine was first included in the 1988 edition of the International Classifi-
cation of Headache Disorders (ICHD) with an internationally agreed definition [8]. In
the latest 2018 ICHD-3, retinal migraine is defined as ‘repeated attacks of monocular vi-
sual disturbance, including scintillation, scotoma, or blindness, associated with migraine
headache’ [9]. These episodes are fully reversible. The full diagnostic criteria of retinal
migraine are included in Box 1.
In this narrative review, we have summarized the literature on retinal migraine as
defined by the latest ICHD, to include epidemiology and risk factors, proposed aetiology,
clinical presentation, and management strategies.
Box 1. ICHD classification of retinal migraine [9].
1. Attacks fulfilling criteria for migraine with aura and the criterion below
2. Attacks fulfilling criteria for migraine without aura and the criterion below
3. Aura characterized by both of the following:
(A) Fully reversible, monocular, positive, and/or negative visual phenomena (e.g., scintillations,
scotomata or blindness) confirmed during an attack by either or both of the following:
• clinical visual field examination
• the patient’s drawing of a monocular field defect (made after clear instruction)
(B) At least two of the following:
• spreading gradually over ≥5 min
• symptoms last 5–60 min
• accompanied, or followed within 60 min, by headache
4. Other causes of amaurosis fugax were excluded, and an episode cannot be accounted for by
another ICHD-3 diagnosis. This is a diagnosis of exclusion.
The ICHD-3 criteria has to meet points 1, 3(A), 3(B), and 4; while the ICHD-2 criteria has to meet
points 2, 3(A), and 4 for a diagnosis of retinal migraine to be made. In the ICHD-2, it was specified
that there should be normal ophthalmological examinations between attacks.
2. Methods
A narrative review was conducted based on the Scale for the Assessment of Narrative
Review Articles (SANRA) principles due to its broad scope and ability to include a range of
information sources. The following databases were searched by the authors Y.Y.C. and A.L.:
Embase Classic, Embase, and Ovid MEDLINE. We used the search term ‘retinal migraine’
and identified 270 articles.
All studies included had a clear research question, appropriate study design, and
discussion of results. Non-English articles and conference proceedings were excluded.
Additional articles that were relevant were hand-searched from Google Scholar and also
identified from citations within articles.
3. Epidemiology and Risk Factors
Retinal migraine is a rare condition and its true incidence is difficult to ascertain due
to a number of factors. Firstly, a consensus-based diagnostic criteria was only established
in the 1988 ICHD. The 1988 ICHD defined retinal migraine as ‘at least two attacks’ of
fully reversible monocular visual disturbance with typical migraine headache, normal
neuro-ophthalmic examination, and exclusion of other causes [8].
Secondly, the diagnostic criteria of retinal migraine has continued to evolve with time.
In 2004, the revised ICHD-2 maintained the same diagnostic criteria, with the difference
that it is associated with headaches that fulfill the criteria for migraine without aura [10].
Grosberg et al., in 2006, summarized the clinical features and prognosis of the largest case
series of retinal migraine patients (40 cases from previous literature, with 6 new cases)
based on the ICHD-2 criteria [11]. Contrary to the ICHD-2 criteria of migraine without
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aura, they showed that half of the patients meeting the definition of retinal migraine had
a history of migraine with aura. The 2018 ICHD-3 criteria was subsequently updated to
‘attacks fulfilling criteria for migraine with aura’ [9].
The same authors also showed that out of the 46 patients with retinal migraine, 28
(61%) were female, with the age of onset ranging from 7 to 54 years old [11]. They further
subcategorized patients based on whether they only showed transient visual loss (TVL), or
subsequently developed permanent visual loss (PVL). Twenty one out of 46 (46%) patients
experienced PVL, with a preponderance for females (15 females compared to 6 males). The
mean age of onset was similar overall in both groups, at 24.7 years for the TVL group and
23.0 years for the PVL group. In females, the peak age of onset was the third and fourth
decade for the TVL group, and second and third decade for the PVL group. A family
history of migraine was documented in 14 out of 46 (30%) of patients.
Thirdly, there are discrepancies in the literature with regards to inclusion criteria for
retinal migraine. Another literature review based on the ICHD-2 criteria was conducted
by Hill et al. in 2007, which included patients from Grosberg et al. in 2006 [12]. Of the
142 patients identified, 103 had transient monocular vision loss (TMVL) attributed to retinal
migraine. Of the 103, only 16 had clinical manifestations for definite retinal migraine with
at least two episodes of TMVL and headaches with a migraine-like phenotype. Of these 16,
only five met the full ICHD-2 criteria for retinal migraine. Six out of 16 were female, with a
mean age of 25.5 years (ranging from 9 to 53 years).
Discrepancies between Grosberg et al. in 2006 and Hill et al. in 2007 are based on
several points of contention. Grosberg et al. included patients who had a single episode
of fully reversible monocular visual phenomena occurring during or within 60 min of a
migraine attack; while Hill et al. only included patients with two episodes of transient
monocular visual loss and headaches suggestive of migraine. Hill et al. also disagreed
with the basis of implicating migraine as the cause of PVL, arguing that most patients
included by Grosberg et al. with retinal migraine did not have IHS-defined retinal migraine
before visual loss. They suggested that the heterogeneity of lesions reported presume
retinal migraines such as arterial and vein occlusions, localized retinal ischaemia, and optic
atrophy cannot be explained by a single unifying mechanism.
An up-to-date review in 2021 by Maher et al. looking at the literature of the past
15 years between 2006 and 2020 identified only 12 cases of retinal migraine based on the
ICHD-3 criteria [13]. Ten out of 12 were female with an average age of 39.5 years. Eleven
out of 12 had a prior history of migraine headaches, with four reporting previous history
of migraine with aura; although the characteristic of migraine with or without aura was
only noted in seven individuals.
The paucity of existing literature and lack of consensus regarding the definition and
inclusion criteria of retinal migraine patients makes our understanding of epidemiology
and risk factors of this condition challenging.
4. Proposed Aetiology
During early embryonic development, the retina and optic nerve emerge from the
diencephalon and are considered as part of the central nervous system [14]. The retina
is composed of different layers of specialized neurons, including retinal ganglion cells
(RGCs), the axons of which form the optic nerve. The axons of the optic nerve continue to
synapse at the lateral geniculate nucleus in the thalamus and then finally to the superior
colliculus in the midbrain as part of the higher cortical visual processing centres, which
allow humans to perceive images of the world [15].
When Carroll described the term retinal migraine in the 1970s, he hypothesized
that the mechanism of visual loss is due to paroxysmal constriction or spasm in either
the central retinal artery or ophthalmic artery [3]. Hill et al., in 2007, argued that most
cases of monocular vision loss purported to be retinal migraine did not meet the ICHD
criteria, and could instead be diagnosed as ‘presumed retinal vasospasm’. In his editorial,
Winterkorn (2007) further added that ‘retinal migraine is an oxymoron’ because the notion
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that a migraine can occur in the retina was derived from the outdated vasospastic theory
of migraine [16]. The vascular or vasospastic hypothesis of migraine has been largely
refuted by advances in intracerebral blood flow imaging [17]. While we still do not fully
understand migraine, advances in the understanding of its pathophysiology indicate a
complex interplay of mechanisms involving hypothalamic activation, alteration in thalamo-
cortical circuits, brainstem activation, cortical spreading depolarisation, release of chemicals
such as calcitonin gene-related peptide (CGRP), and pituitary adenylate cyclase activating
polypeptide (PACP) [18]. A study that mapped out the visual precept of aura in a migraine
showed that these attacks tend to originate in the central visual field, before spreading
peripherally, with a speed of 2–3 mm/min. This further suggests the involvement of
the visual cortex [19]. If we accept that the visual aura is a cortical process that results
in binocular symptoms, the term retinal migraine becomes potentially confusing and
anatomically incongruous. We are referring to cortical mechanisms as though they are
occurring in the retina [16].
Kosmorsky argued that there is no definitive way to tell if a vasospastic process is
secondary to focally-generated chemicals or mediated neuronally from migraine [20]. He
demonstrated a case of a 30-year-old women with 8–10 episodes of recurrent symptoms of
flashing lights, grey out, and loss of vision leading to no perception of light (NPL), which
was solely monocular to the right eye and in the absence of headache. Fundus fluorescein
angiography (FFA) performed while she was symptomatic with NPL vision (corroborated
with an afferent pupillary defect) showed delayed central retinal artery circulation with
normal choroidal circulation. Within 2 h, she completely regained her vision in the right
eye. A repeat FFA 2 days later was normal and other investigations did not identify a
cause for her monocular visual loss. Although this case did not meet the ICHD criteria of
retinal migraine, the author explained that focal vasospasm alone as an explanation was
inadequate as one would not expect circulating vasoactive molecules to induce spasm in
the same vascular distribution.
To further support the theory that retinal migraine is a distinct entity from retinal
vasospasm, Ota et al. recorded a fundus video of a 29-year-old women with a 10-year
history of migraine with aura, and monocular symptoms meeting the ICHD-3 criteria,
while the patient was symptomatic [21]. The 1 min and 55 s video showed dynamic changes
in the fundus over time, with narrowing of retinal arteries and veins initially, and blood
columns in the veins interrupted with a rouleaux formation, pale optic disc, and dark
choroid. The narrowing of the retinal vessels and disc pallor diminished gradually during
the course of the video, with dilated retinal vessels and hyperaemic disc after 1 min and 28 s.
They speculated that the ophthalmic artery was the main component of vasoconstriction,
with vasodilation at the end of the attack representing compensation for retinal hypoxia.
Lastly, several authors have proposed the cortical spreading depression (CSD) the-
ory of retinal neurons as a plausible explanation [5,13,22]. Cortical spreading depression
was first described by Leao in the cortex of rabbits, whereby a slow propagating wave
of neuronal depolarization through grey matter is followed by depression of neuronal
activity [23]. CSD is one of the purported biological mechanisms of the visual symptoms
experience in patients with migraine with aura, although this has not directly been demon-
strated in humans to date. An initial brief hyperaemic phase is followed by prolonged
oligaemia, starting in the occipital lobe and spreading rostrally across the cortex [23]. This
is supported by evidence that SD occurs in chicken retina involving CGRP receptors [24,25].
5. Clinical Presentation
Visual disturbances in the context of headache and ocular pain are common [26]. The
important distinction is in the characterisation of the visual disturbance and associated
visual symptoms [27]. The most important distinguishing feature for a diagnosis of retinal
migraine compared to visual aura experienced in those with migraines lies in its strict
monocular presentation. In migraine with aura, visual symptoms often present as complex
patterns, such as: fortification spectra (zig zag figure near the point of fixation with an
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angulated scintillating edge), followed by variable degrees of relative scotoma, typically
lasting between 5 to 60 min [9,27]. The binocular and homonymous nature of these
symptoms often lead to incorrect descriptions by patients, attributing homonymous visual
phenomena as monocular. This relates to the greater relative size of the temporal visual
fields (extending out to 90 degrees) compared to the nasal visual field (extending out to
60 degrees), resulting in attribution of monocular field loss in the eye with the temporal
defect [28].
In contrast with migraine with visual aura, most retinal migraine cases reported
to date present with negative symptoms (such as visual field defects including central
scotoma, altitudinal visual loss, or sectorial loss): shown by 12 out of 16 cases by Hill et al.,
and 11 out of 12 cases by Maher et al.
Retinal migraine is a diagnosis of exclusion only after other causes of TMVL have
been excluded. In particular, conditions such as amaurosis fugax, carotid artery occlusive
disease, and arteritic disease such as giant cell arteritis (GCA) should be considered.
In amaurosis fugax, interrupted blood flow to the central retinal artery or ophthalmic
artery can cause symptoms of a blackout in the whole or half of the visual field. Patients
can report a ‘curtain’ sweeping in from one side of the vision. This is temporary and
typically resolves within minutes and lasts no longer than an hour. It can be caused by
thromboembolism originating from an atherosclerotic plaque in the internal carotid artery,
or an embolus originating from the heart or aorta. When associated with atheromatous
disease, there is a 2% risk of recurrent stroke at 1 year; while those with severe internal
carotid artery stenosis have an increased risk of ipsilateral stroke of up to 16% after
3 years [29]. An embolus can also originate from a carotid artery dissection. Arteritis such
as GCA is another serious cause of TMVL that can be associated with headache [30].
Other causes of TMVL include ocular diseases such as dry eyes and intermittent
angle closure glaucoma; optic nerve disorders such as papilloedema with transient visual
obscurations; and other vascular diseases such as choroidal ischaemia from the posterior
ciliary arteries. As there are a number different diagnoses for TMVL, patients presenting
these symptoms should be examined by an ophthalmologist.
6. Investigation
In the context of a patient presenting with symptoms fulfilling the ICHD-3 criteria
for retinal migraine, the first priority is to perform the necessary investigations to rule
out other causes of TMVL as shown in Table 1. This includes a detailed medical history
from the patient, specifically the characteristic, frequency, and duration of vision loss. It
would also be helpful to discern if the patient has a history of migraine with or without
aura. Following this, patients should undergo a thorough ophthalmological examination
including formal visual fields, ideally with documentation of the fundus with photography
and optical coherence tomography (OCT). It may be prudent to perform baseline OCT
angiography at the disc and within the macular region, should the opportunity arise in
the future to capture an episode. To exclude other vaso-occlusive disease, carotid Doppler
imaging may be used, and where arteritic processes are involved, inflammatory markers
should be evaluated and specific features of the history be excluded [31].
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Table 1. Examples of differential diagnosis of TMVL.
Disease Category Examples
Vascular disease Carotid artery disease (amaurosis fugax)
Giant Cell Arteritis
Central retinal artery occlusion
Choroidal ischaemia from posterior ciliary arteries
Other arteritis processes that affect the short posterior
ciliary arteritis
Ocular disease Dry eyes
Intermittent angle closure glaucoma
Optic nerve disorders Papilloedema with transient visual obscuration
Uhthoff’s phenomenon from demyelinating disease
Optic nerve compression (either gaze evoked visual
loss or transient visual obscuration)
7. Management Strategies
Given the few numbers of cases in the existing literature, evidence-based treatment
options for retinal migraine are limited. There have been different case reports advocating
the use of migraine-based therapies such as propranolol, imipramine, nortriptyline, and
verapamil [11,32,33]. Some authors have suggested not using beta-blockers due to the
theoretical risk of arteriolar constriction [33]. In others, the symptoms of retinal migraine
are managed conservatively by observations alone [21,34].
8. Conclusions
Retinal migraine is a very rare cause of TMVL. Newer imaging modalities, such as
OCT and OCT angiography, may in the future help provide better understanding and
quantification of the retinal and vascular changes that have previously been reported.
As retinal migraine is a diagnosis of exclusion, patients who present with TMVL need
extensive work to exclude other causes of monocular vision loss. Future research in this
distinct clinical entity is needed, as the term “retinal migraine” may be a misnomer that
confuses clinicians and patients alike.
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